The reliance on generic products may expose Teva to increased competition and price pressures in the market, raising concerns about the sustainability of its business model
Acta Diabetol (1998) 35: 117-129
GH Release Comparison Approximate GH pulse amplitude at standard doses (from published research): Note: Individual response varies significantly
We have to address this problem. In a written statement, a Lilly spokesperson said reforms in SB 282 will help protect patients from dangerous ingredients from foreign sources. Patients deserve better than untested knockoffs that are sold without clinical evidence that they are safe or even work, the statement sent by Lilly Associate Director of Public Affairs Jared Shapiro said
Intended to balance innovation and familiarity, Aidaptus is a two-step, single-use autoinjector with a versatile hybrid design that can accommodate both a 1 and 2.25 mL prefilled syringe in the same form factor
Dihexa and Semax both target neuroplasticity but through entirely different mechanisms